(Q40923203)

English

Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy

scientific article published on 2 November 2015

Statements

Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy (English)
Lambert Assoumou
Martine Alhenc-Gelas
Elena-Maria Manea
IMEA 043-CESAR trial working group

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit